(Q48569095)

12 February 2018

title

Selective effects on prefrontal cortex serotonin by dopamine D3 receptor agonism: interaction with low-dose haloperidol. (English)

1 reference

12 February 2018

author name string

Lynch MR

series ordinal

1

1 reference

12 February 2018

publication date

1 October 1997

1 reference

12 February 2018

Progress in Neuro-Psychopharmacology & Biological Psychiatry

published in

1 reference

12 February 2018

volume

21

1 reference

12 February 2018

page(s)

1141-1153

1 reference

12 February 2018

issue

7

1 reference

12 February 2018

Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Serotonin2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Clinical efficacy of serotonin-dopamine antagonists relative to classic neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through the substantia nigra pars compacta and ventral tegmental area

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Effects of clozapine, thioridazine, perlapine and haloperidol on the metabolism of the biogenic amines in the brain of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Lack of discrimination by agonists for D2 and D3 dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Radioreceptor binding profile of the atypical antipsychotic olanzapine.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double-blind comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Pharmacological effects of zotepine and other antipsychotics on the central 5-HT2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Pharmacological aspects of R-(+)-7-OH-DPAT, a putative dopamine D3 receptor ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Dopamine in schizophrenia: a review and reconceptualization

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Biochemical and electrophysiological effects of 7-OH-DPAT on the mesolimbic dopaminergic system

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Influence of antipsychotics and serotonin antagonists on presynaptic receptors modulating the release of serotonin in synaptosomes of the nucleus accumbens of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Ritanserin, a selective 5-HT2/1C antagonist, and negative symptoms in schizophrenia. A placebo-controlled double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

[3H]7-OH-DPAT is capable of labeling dopamine D2 as well as D3 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Antagonism of quinpirole by (+)-AJ 76: possible involvement of D3 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Pharmacology of dopamine D3 receptors in the islands of Calleja of the rat using quantitative receptor autoradiography

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Effects of the preferential dopamine autoreceptor antagonist (+)-AJ76 in the intracranial self-stimulation paradigm.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Dopamine receptor agonist potencies for inhibition of cell firing correlate with dopamine D3 receptor binding affinities

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Activation of dopamine D3 autoreceptors inhibits firing of ventral tegmental dopaminergic neurones in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Relative affinities of dopaminergic drugs at dopamine D2 and D3 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Acute haloperidol attenuates the hypomotility induced with 7-hydroxy-DPAT.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Effect of amperozide on rat cortical 5-HT2 and striatal and limbic dopamine D2 receptor occupancy: implications for antipsychotic action

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Neurological signs and the positive-negative dimension in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Effects of Mianserin on Negative Symptoms in Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

The influence of serotoninergic drugs on dopaminergic neurotransmission in rat substantia nigra, striatum and limbic forebrain in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Electrophysiological, biochemical and behavioral evidence for 5-HT2 and 5-HT3 mediated control of dopaminergic function

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

A comparison of plasma homovanillic acid in the deficit and nondeficit subtypes of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Effect of clozapine on the metabolism of serotonin in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

A functional test identifies dopamine agonists selective for D3 versus D2 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Serotonin innervation in adult rat neostriatum. I. Quantified regional distribution.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

The third dopamine receptor (D3) as a novel target for antipsychotics

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

(+)-AJ 76 and (+)-UH 232: central stimulants acting as preferential dopamine autoreceptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Locomotor inhibition by the D3 ligand R-(+)-7-OH-DPAT is independent of changes in dopamine release

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Clozapine response in treatment-refractory first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Phenomenological correlates of metabolic activity in 18 patients with chronic schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

The dopamine D3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Negative symptoms and hypofrontality in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

Regulation of nucleus accumbens dopamine release by the dorsal raphe nucleus in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900106-1

7 January 2021

10.1016/S0278-5846(97)00106-1

Identifiers

DOI

1 reference

12 February 2018

PubMed ID

9421827

1 reference

12 February 2018